Name: Formulation and evaluation of nanoparticles for targeting kidney and treating kidney stone (en Inglés)
Price: 39540.00 CLP
Availability: InStock
Author: Kandav, Gurpreet
ISBN: 9784034858257

portada Formulation and evaluation of nanoparticles for targeting kidney and treating kidney stone (en Inglés)

Formato

Libro Físico

Autor

Gurpreet Kandav

Editorial

Ary Publisher

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.4 cm

Peso

0.11 kg.

ISBN13

9784034858257

Categorías

Enfermedades y trastornos
Medicina renal y nefrología

Formulation and evaluation of nanoparticles for targeting kidney and treating kidney stone (en Inglés)

Gurpreet Kandav (Autor) · Ary Publisher · Tapa Blanda

Libro Nuevo

$ 39.540

$ 54.910

Ahorras: $ 15.370

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 02 de Agosto y el Miércoles 14 de Agosto.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Formulation and evaluation of nanoparticles for targeting kidney and treating kidney stone (en Inglés)"

This research work focuses on developing and evaluating nanoparticles containing allopurinol for the management of uric acid nephrolithiasis. The study formulated three different nanoparticles - magnetic nanoparticles, bovine serum albumin (BSA) nanoparticles, and chitosan nanoparticles - using different methods and characterized them based on particle size, polydispersity index, zeta potential, entrapment efficiency, FTIR spectra, DSC thermograms, XRD patterns, TEM images, and in vitro drug release. The in vivo targeting potential of the nanoparticles was evaluated in mice, and the effectiveness of the nanoparticles was tested in managing hyperuricemic nephrolithiasis by measuring pH and uric acid levels in urine and serum samples of mice. Histological examination of kidney samples was also performed to confirm the outcomes. The results showed that the nanoparticles prepared from low MW chitosan polymer exhibited maximum kidney targeting potential and efficacy in managing hyperuricemia-related nephrolithiasis. This research could potentially lead to the development of a targeted therapy for uric acid nephrolithiasis.